Clinical Trial Update: A Prescription-Event Monitoring (PEM) Study of Tiotropium

View source ↗

Summary

This document notes the completion of a Prescription-Event Monitoring study evaluating tiotropium for chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED